Mesenchymal stem cell therapy for severe COVID-19

The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has placed a global public burden on health authorities. Although the virological characteristics and pathogenesis of COVID-19 has been largely clarified, there is currently no specific t...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Lei, Wang, Lifeng, Xu, Ruonan, Zhang, Chao, Xie, Yunbo, Liu, Kai, Li, Tiantian, Hu, Wei, Zhen, Cheng, Wang, Fu-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424619/
https://www.ncbi.nlm.nih.gov/pubmed/34497264
http://dx.doi.org/10.1038/s41392-021-00754-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424619/
https://www.ncbi.nlm.nih.gov/pubmed/34497264
http://dx.doi.org/10.1038/s41392-021-00754-6

Ejemplares similares